FDA 483 - BioRamo, LLC - January 30, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
BioRamo, LLC, a drug manufacturer in Ft Lauderdale, FL, was inspected by the FDA and cited for significant deficiencies. The firm's quality control unit failed to follow written procedures, specifically regarding inadequate investigations and lack of documented final product release. Additionally, the inspection revealed failures in handling and storing materials, leading to potential contamination risks due to poor inventory tracking and insufficient storage procedures.
- Office
- Florida District Office
- Person
ID · 94b7004c-d0b0-4243-825e-40c0c20aca30